ONCOSEC MEDICAL INCORPORATED: 10-K filed 2016-10-13
What ONCOSEC MEDICAL INCORPORATED reported in its annual report filed 2016-10-13 (fiscal FY 2016): 24 published measures, 72 facts as tagged in accession 0001493152-16-013999.
This filing
- Form
- 10-K (annual report)
- Filed
- 2016-10-13
- Fiscal period
- fiscal FY 2016
- Accession
- 0001493152-16-013999 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ONCOSEC MEDICAL INCORPORATED filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | 32,406,647 | USD | |
| At 2015-07-31 | 35,590,090 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | 4,353,543 | USD | |
| At 2015-07-31 | 2,894,469 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | 28,053,104 | USD | |
| At 2015-07-31 | 32,695,621 | USD | |
| At 2014-07-31 | 38,068,058 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | 28,746,224 | USD | |
| At 2015-07-31 | 32,035,264 | USD | |
| At 2014-07-31 | 37,852,694 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-05-01 to 2016-07-31 | -6,561,994 | USD | 92 |
| 2015-08-01 to 2016-07-31 | -26,888,514 | USD | 366 |
| 2016-02-01 to 2016-04-30 | -6,251,409 | USD | 90 |
| 2015-11-01 to 2016-01-31 | -7,037,720 | USD | 92 |
| 2015-08-01 to 2015-10-31 | -7,037,391 | USD | 92 |
| 2015-05-01 to 2015-07-31 | -6,576,413 | USD | 92 |
| 2014-08-01 to 2015-07-31 | -21,243,111 | USD | 365 |
| 2015-02-01 to 2015-04-30 | -5,987,345 | USD | 89 |
| 2014-11-01 to 2015-01-31 | -4,618,237 | USD | 92 |
| 2014-08-01 to 2014-10-31 | -4,061,116 | USD | 92 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2016-07-31 | 1,470,635 | USD | 366 |
| 2014-08-01 to 2015-07-31 | 1,412,217 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | -73,494,657 | USD | |
| At 2015-07-31 | -46,606,143 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2016-07-31 | 2,462 | USD | 366 |
| 2014-08-01 to 2015-07-31 | 1,969 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | 2,799,930 | USD | |
| At 2015-07-31 | 1,807,982 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2016-07-31 | 16,000 | USD | 366 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-05-01 to 2016-07-31 | -6,561,994 | USD | 92 |
| 2015-08-01 to 2016-07-31 | -26,886,052 | USD | 366 |
| 2016-02-01 to 2016-04-30 | -6,251,119 | USD | 90 |
| 2015-11-01 to 2016-01-31 | -7,037,720 | USD | 92 |
| 2015-08-01 to 2015-10-31 | -7,035,219 | USD | 92 |
| 2015-05-01 to 2015-07-31 | -6,576,413 | USD | 92 |
| 2014-08-01 to 2015-07-31 | -21,241,142 | USD | 365 |
| 2015-02-01 to 2015-04-30 | -5,986,286 | USD | 89 |
| 2014-11-01 to 2015-01-31 | -4,618,237 | USD | 92 |
| 2014-08-01 to 2014-10-31 | -4,060,206 | USD | 92 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | 29,417,408 | USD | |
| At 2015-07-31 | 33,567,981 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | 3,466,251 | USD | |
| At 2015-07-31 | 2,861,951 | USD |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | 18,036,263 | shares | |
| At 2015-07-31 | 14,820,854 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | 88,233,965 | USD | |
| At 2015-07-31 | 71,572,714 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | 3,243,611 | USD | |
| At 2015-07-31 | 2,138,524 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | 443,681 | USD | |
| At 2015-07-31 | 330,542 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | 189,309 | USD | |
| At 2015-07-31 | 214,127 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-07-31 | 887,292 | USD | |
| At 2015-07-31 | 32,518 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-05-01 to 2016-07-31 | -6,561,994 | USD | 92 |
| 2008-08-08 to 2016-07-31 | -73,500,000 | USD | 2915 |
| 2016-02-01 to 2016-04-30 | -6,251,409 | USD | 90 |
| 2015-11-01 to 2016-01-31 | -7,037,720 | USD | 92 |
| 2015-08-01 to 2015-10-31 | -7,037,391 | USD | 92 |
| 2015-05-01 to 2015-07-31 | -6,576,413 | USD | 92 |
| 2015-02-01 to 2015-04-30 | -5,987,345 | USD | 89 |
| 2014-11-01 to 2015-01-31 | -4,618,237 | USD | 92 |
| 2014-08-01 to 2014-10-31 | -4,061,116 | USD | 92 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2016-07-31 | 12,144,358 | USD | 366 |
| 2014-08-01 to 2015-07-31 | 8,108,244 | USD | 365 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2016-07-31 | 356,000 | USD | 366 |
| 2014-08-01 to 2015-07-31 | 200,000 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2016-07-31 | 355,583 | USD | 366 |
| 2014-08-01 to 2015-07-31 | 664,596 | USD | 365 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2016-07-31 | 2,462 | USD | 366 |
| 2014-08-01 to 2015-07-31 | 1,969 | USD | 365 |
Inspect the source
- Entity
- ONCOSEC MEDICAL INCORPORATED / CIK 0001444307
- Captured
- SEC response SHA-256
326bcab6a98b5e6098a865fe967c999ac8b3247d9466d112c5306da6df2f5607
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001444307.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))